Kyoto, Japan

Arkray, Inc.


USPTO Granted Patents = 567

% Expired Patents = 14.6



Trademarks = 33

Forward Citations = 6,153

Loading Chart...
Loading Chart...

373 inventors (with patents filed for the assignee):

goldMedal Satoshi Yonehara (38 out of 43 patents)

silverMedal Koji Katsuki (24 out of 24 patents)

bronzeMedal Yasunori Shiraki (23 out of 23 patents)

4.  Daisuke Matsumoto (22 out of 23 patents)

5.  Yoshiharu Sato (22 out of 25 patents)

6.  Shigeru Kitamura (21 out of 21 patents)

7.  Masahiro Fukuzawa (19 out of 19 patents)

8.  Naotsugu Onuma (18 out of 18 patents)

9.  Koji Sode (17 out of 46 patents)

10.  Shinya Nakajima (17 out of 20 patents)

11.  Yasuhide Kusaka (17 out of 17 patents)

12.  Mitsuharu Hirai (16 out of 16 patents)

13.  Hideaki Yamaoka (15 out of 15 patents)

14.  Tokuo Kasai (14 out of 15 patents)

15.  Tetsuya Sakata (14 out of 15 patents)


Core Competencies:
Biosensor
Measurement System
Analysis Device
Liquid Chromatography
Sample Analysis
Electrochemical Sensor
Particle Recovery
Optical Element
Urine Analyzer
Fluids Delivery
Nucleic Acid Aptamer
Glycoprotein Measurement

567 patents:

ARKRAY, Inc. is a global organization that develops, manufactures, and markets innovative diagnostic products for healthcare providers. With a focus on diabetes management and urinalysis, ARKRAY aims to improve the quality of life for individuals through advanced medical technologies. The company is committed to offering reliable and user-friendly devices, and its products range from blood glucose monitoring systems to automatic urine analyzers. With a history dating back to 1960, ARKRAY continues to make advancements in medical diagnostics and contribute to the well-being of people worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Arkray, Inc.
567 Patents

#20 in Kyoto 615-0031

#353 in Japan

#1,716 in the World

Kyoto, JP
Kyoto, Japan
Forward Citations = 6,153

373 inventors:

Please report any incorrect information to [email protected]
Loading…